<?xml version="1.0" encoding="UTF-8"?>
<p>Since the results of clinical trials can be different from those obtained from in vitro studies a special reference is made to clinical trials regarding nutrient/foods and PAF metabolism (
 <xref rid="nutrients-13-00462-t001" ref-type="table">Table 1</xref>). As it can be seen, the majority of studies have focused on platelet aggregation [
 <xref rid="B153-nutrients-13-00462" ref-type="bibr">153</xref>,
 <xref rid="B154-nutrients-13-00462" ref-type="bibr">154</xref>,
 <xref rid="B162-nutrients-13-00462" ref-type="bibr">162</xref>,
 <xref rid="B191-nutrients-13-00462" ref-type="bibr">191</xref>,
 <xref rid="B197-nutrients-13-00462" ref-type="bibr">197</xref>,
 <xref rid="B203-nutrients-13-00462" ref-type="bibr">203</xref>,
 <xref rid="B204-nutrients-13-00462" ref-type="bibr">204</xref>,
 <xref rid="B205-nutrients-13-00462" ref-type="bibr">205</xref>,
 <xref rid="B206-nutrients-13-00462" ref-type="bibr">206</xref>,
 <xref rid="B207-nutrients-13-00462" ref-type="bibr">207</xref>] and/or PAF catabolic enzymes [
 <xref rid="B108-nutrients-13-00462" ref-type="bibr">108</xref>,
 <xref rid="B206-nutrients-13-00462" ref-type="bibr">206</xref>,
 <xref rid="B208-nutrients-13-00462" ref-type="bibr">208</xref>,
 <xref rid="B209-nutrients-13-00462" ref-type="bibr">209</xref>,
 <xref rid="B210-nutrients-13-00462" ref-type="bibr">210</xref>,
 <xref rid="B211-nutrients-13-00462" ref-type="bibr">211</xref>,
 <xref rid="B212-nutrients-13-00462" ref-type="bibr">212</xref>,
 <xref rid="B213-nutrients-13-00462" ref-type="bibr">213</xref>,
 <xref rid="B214-nutrients-13-00462" ref-type="bibr">214</xref>,
 <xref rid="B215-nutrients-13-00462" ref-type="bibr">215</xref>] and had promising results in both healthy subjects [
 <xref rid="B108-nutrients-13-00462" ref-type="bibr">108</xref>,
 <xref rid="B154-nutrients-13-00462" ref-type="bibr">154</xref>,
 <xref rid="B162-nutrients-13-00462" ref-type="bibr">162</xref>,
 <xref rid="B197-nutrients-13-00462" ref-type="bibr">197</xref>,
 <xref rid="B198-nutrients-13-00462" ref-type="bibr">198</xref>,
 <xref rid="B206-nutrients-13-00462" ref-type="bibr">206</xref>,
 <xref rid="B207-nutrients-13-00462" ref-type="bibr">207</xref>,
 <xref rid="B216-nutrients-13-00462" ref-type="bibr">216</xref>] and high-risk individuals [
 <xref rid="B153-nutrients-13-00462" ref-type="bibr">153</xref>,
 <xref rid="B191-nutrients-13-00462" ref-type="bibr">191</xref>,
 <xref rid="B204-nutrients-13-00462" ref-type="bibr">204</xref>,
 <xref rid="B208-nutrients-13-00462" ref-type="bibr">208</xref>,
 <xref rid="B209-nutrients-13-00462" ref-type="bibr">209</xref>,
 <xref rid="B210-nutrients-13-00462" ref-type="bibr">210</xref>,
 <xref rid="B211-nutrients-13-00462" ref-type="bibr">211</xref>,
 <xref rid="B212-nutrients-13-00462" ref-type="bibr">212</xref>,
 <xref rid="B213-nutrients-13-00462" ref-type="bibr">213</xref>,
 <xref rid="B214-nutrients-13-00462" ref-type="bibr">214</xref>,
 <xref rid="B215-nutrients-13-00462" ref-type="bibr">215</xref>,
 <xref rid="B217-nutrients-13-00462" ref-type="bibr">217</xref>,
 <xref rid="B218-nutrients-13-00462" ref-type="bibr">218</xref>,
 <xref rid="B219-nutrients-13-00462" ref-type="bibr">219</xref>,
 <xref rid="B220-nutrients-13-00462" ref-type="bibr">220</xref>,
 <xref rid="B221-nutrients-13-00462" ref-type="bibr">221</xref>,
 <xref rid="B222-nutrients-13-00462" ref-type="bibr">222</xref>]. Additionally, ongoing or recently finished clinical trials regarding CODIV-19 are displayed in 
 <xref rid="nutrients-13-00462-t002" ref-type="table">Table 2</xref>. It is noted that only nutrients or foods which may modulate PAF and/or its enzymes are displayed. To our knowledge there is no ongoing trial with such nutrients and PAF measurement as an end point.
</p>
